| 臺大學術典藏 |
2021-01-15T03:47:25Z |
Age is not a discriminating factor for outcomes of therapeutic upper gastrointestinal endoscopy
|
Lee T.-C.; Huang S.-P.; Yang J.-Y.; Chang C.-Y.; Liou J.-M.; Liu C.-H.; Huang M.-S.; HSIU-PO WANG |
| 臺大學術典藏 |
2021-01-15T03:47:24Z |
The serial changes of ghrelin and leptin levels and their relations to weight loss after laparoscopic minigastric bypass surgery
|
Liou J.-M.; Lin J.-T.; Lee W.-J.; HSIU-PO WANG; Lee Y.-C.; Chiu H.-M.; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:47:21Z |
RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women
|
Liou J.-M.; Lin J.-T.; Huang S.-P.; Wu C.-Y.; HSIU-PO WANG; Lee Y.-C.; Chiu H.-M.; Shun C.-T.; Lin M.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:47:17Z |
Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage
|
Hsu Y.-C.; Chung C.-S.; Tseng C.-H.; Lin T.-L.; Liou J.-M.; Wu M.-S.; Hu F.-C.; HSIU-PO WANG |
| 臺大學術典藏 |
2021-01-15T03:47:12Z |
Emergency endoscopy for upper gastrointestinal bleeding in patients with coronary artery disease
|
Tseng P.-H.; Liou J.-M.; Lee Y.-C.; Lin L.-Y.; Yan-Zhen Liu A.; Chang D.-C.; Chiu H.-M.; Wu M.-S.; Lin J.-T.; HSIU-PO WANG |
| 臺大學術典藏 |
2021-01-15T03:47:11Z |
Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria
|
Hsu Y.-C.; Liou J.-M.; Liao S.-C.; Yang T.-H.; Wu H.-T.; Hsu W.-L.; Lin H.-J.; HSIU-PO WANG; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:47:09Z |
Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer
|
Liou J.-M.; Shun C.-T.; Liang J.-T.; Chiu H.-M.; Chen M.-J.; Chen C.-C.; HSIU-PO WANG; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-01-15T03:47:08Z |
A 61-year-old man with abdominal pain for 6 months
|
Tseng C.-H.; Liou J.-M.; Liu K.-L.; HSIU-PO WANG |
| 臺大學術典藏 |
2021-01-15T03:47:08Z |
Early risk stratification with simple clinical parameters for cirrhotic patients with acute upper gastrointestinal bleeding
|
Hsu Y.-C.; Liou J.-M.; Chung C.-S.; Tseng C.-H.; Lin T.-L.; Chen C.-C.; Wu M.-S.; HSIU-PO WANG |
| 臺大學術典藏 |
2021-01-15T03:47:07Z |
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: A randomised comparative trial with crossover design
|
Liou J.-M.; Lin J.-T.; Chang C.-Y.; Chen M.-J.; Cheng T.-Y.; Lee Y.-C.; Chen C.-C.; Sheng W.-H.; HSIU-PO WANG; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:47:06Z |
The passage of a colonic cast
|
Su T.-H.; Liou J.-M.; HSIU-PO WANG |
| 臺大學術典藏 |
2021-01-15T03:47:03Z |
Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: Is therapeutic response predicted by Rome III subgroups?
|
Hsu Y.-C.; Liou J.-M.; Yang T.-H.; Hsu W.-L.; Lin H.-J.; Wu H.-T.; Lin J.-T.; HSIU-PO WANG; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:47:01Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Sheng W.-H.; HSIU-PO WANG; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2021-01-15T03:47:00Z |
Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population
|
Liou J.-M.; Wu M.-S.; Shun C.-T.; Chiu H.-M.; Chen M.-J.; Chen C.-C.; HSIU-PO WANG; Lin J.-T.; Liang J.-T. |
| 臺大學術典藏 |
2021-01-15T03:46:57Z |
Can clinical features stratify use of endoscopy for dyspeptic patients with high background prevalence of upper gastrointestinal cancer?
|
Hsu Y.-C.; Yang T.-H.; Liou J.-M.; Hsu W.-L.; Lin H.-J.; Wu H.-T.; Lin J.-T.; HSIU-PO WANG; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:46:56Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; Wu M.-S.; HSIU-PO WANG; Lin J.-T. |
| 臺大學術典藏 |
2021-01-15T03:46:54Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; HSIU-PO WANG; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:46:53Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; HSIU-PO WANG; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-01-15T03:46:50Z |
Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions
|
Lee Y.-C.; Chiu H.-M.; Chiang T.-H.; Yen A.M.-F.; Chiu S.Y.-H.; Chen S.L.-S.; Fann J.C.-Y.; Yeh Y.-P.; Liao C.-S.; Hu T.-H.; Tu C.-H.; Tseng P.-H.; Chen C.-C.; Chen M.-J.; Liou J.-M.; Liao W.-C.; Lai Y.-P.; Wang C.-P.; Ko J.-Y.; HSIU-PO WANG; Chiang H.; Lin J.-T.; Chen H.-H.; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:46:49Z |
Tag single nucleotide polymorphisms of alcohol-metabolizing enzymes modify the risk of upper aerodigestive tract cancers: HapMap database analysis
|
Chung C.-S.; Lee Y.-C.; Liou J.-M.; Wang C.-P.; Ko J.-Y.; Lee J.-M.; Wu M.-S.; HSIU-PO WANG |
| 臺大學術典藏 |
2021-01-15T03:46:48Z |
Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis
|
Han M.-L.; Chen C.-C.; Kuo S.-H.; Hsu W.-F.; Liou J.-M.; Wu M.-S.; HSIU-PO WANG |
| 臺大學術典藏 |
2021-01-15T03:46:43Z |
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan
|
Cheng A.; Sheng W.-H.; Liou J.-M.; HSIU-PO WANG; Wu M.-S.; Lin J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-01-15T03:46:42Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; HSIU-PO WANG; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-01-15T03:46:41Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; HSIU-PO WANG; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:46:40Z |
Associations of circulating gut hormone and adipocytokine levels with the spectrum of gastroesophageal reflux disease
|
Tseng P.-H.; Yang W.-S.; Liou J.-M.; Lee Y.-C.; HSIU-PO WANG; Lin J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:46:39Z |
Statins and the risk of pancreatic cancer in Type 2 diabetic patients - A population-based cohort study
|
Chen M.-J.; Tsan Y.-T.; Liou J.-M.; Lee Y.-C.; Wu M.-S.; Chiu H.-M.; HSIU-PO WANG; Chen P.-C. |
| 臺大學術典藏 |
2021-01-15T03:46:38Z |
Massive left pleural effusion after endoscopic variceal therapy
|
Wu W.-K.; HSIU-PO WANG; Liou J.-M.; Wu M.-S.; Chen Y.-T. |
| 臺大學術典藏 |
2021-01-15T03:46:35Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; HSIU-PO WANG; Cheng A.-L.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-01-15T03:46:33Z |
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo S.-H.; Yeh K.-H.; Wu M.-S.; Lin C.-W.; Wei M.-F.; Liou J.-M.; HSIU-PO WANG; Chen L.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-15T03:46:23Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; Wang T.-E.; HSIU-PO WANG; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-12-29T03:09:27Z |
Phaeohyphomycosis caused by Exophiala species in immunocompromised hosts
|
Hsueh P.-R.; Wang S.-S.; Wang M.-H.; JANN-TAY WANG; Liou J.-M.; Liou J.-M.;Jann-Tay Wang;Wang M.-H.;Wang S.-S.;Hsueh P.-R. |
| 臺大學術典藏 |
2020-12-28T12:04:31Z |
Applying a multiple screening program aided by a guideline-driven computerized decision support system - A pilot experience in Yun-Lin, Taiwan
|
Lin J.-W.; Chu P.-L.; Liou J.-M.; HWANG, JUEY-JEN |
| 臺大學術典藏 |
2020-12-28T06:25:51Z |
Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer
|
Li Y.-I.; Liang J.-T.; Li H.-Y.; Su C.-Y.; Hung J.-S.; Yu T.-Y.; Liou J.-M.; Wei J.-N.; HSIEN-LI KAO; Chuang L.-M.; Shun C.-T.; Lee P.-H.; Lai H.-S. |
| 臺大學術典藏 |
2020-12-18T07:26:30Z |
Measurement of visceral Fat: Should we include
|
Liu P.-H.; MAO-HSIN LIN; Hung C.-S.; Lee J.-K.; Yang C.-Y.; Hsieh H.-R.; Ma W.-Y.; Shih S.-R.; Liou J.-M.; Chuang L.-M.; Chen M.-F.; Lin J.-W.; Wei J.-N.; Li H.-Y. |
| 臺大學術典藏 |
2020-12-18T07:26:26Z |
The Impact of Gastric Atrophy on the Incidence of Diabetes
|
Yu T.-Y.; Wei J.-N.; Kuo C.-H.; Liou J.-M.; MAO-HSIN LIN; Shih S.-R.; Hua C.-H.; Hsein Y.-C.; Hsu Y.-W.; Chuang L.-M.; Lee M.-K.; Hsiao C.-H.; Wu M.-S.; Li H.-Y. |
| 臺大學術典藏 |
2020-12-04T07:45:18Z |
Emergency endoscopy for upper gastrointestinal bleeding in patients with coronary artery disease
|
Tseng P.-H.; Liou J.-M.; Lee Y.-C.; LIAN-YU LIN; Yan-Zhen Liu A.; Chang D.-C.; Chiu H.-M.; Wu M.-S.; Lin J.-T.; Wang H.-P. |
| 臺大學術典藏 |
2020-11-30T07:35:46Z |
Association between Helicobacter pylori infection and cognitive impairment in the elderly
|
Han M.-L.;Jen-Hau Chen;Tsai M.-K.;Liou J.-M.;Chiou J.-M.;Chiu M.-J.;Chen Y.-C.; Han M.-L.; JEN-HAU CHEN; Tsai M.-K.; Liou J.-M.; Chiou J.-M.; Chiu M.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2020-11-27T03:28:41Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-27T03:28:41Z |
Early risk stratification with simple clinical parameters for cirrhotic patients with acute upper gastrointestinal bleeding
|
Hsu Y.-C.; Liou J.-M.; Chung C.-S.; Tseng C.-H.; Lin T.-L.; CHIEH-CHANG CHEN; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2020-11-27T03:28:40Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chien-Chuan Chen; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-27T03:28:40Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chen M.-J.; Chien-Chuan Chen; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2020-11-27T03:28:39Z |
Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection
|
Chen M.-J.; Liou J.-M.; CHIEH-CHANG CHEN; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2020-11-27T03:28:39Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; CHIEH-CHANG CHEN; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chien-Chuan Chen; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2020-11-27T03:28:39Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Liou J.-M.; Chang C.-Y.; Chen M.-J.; CHIEH-CHANG CHEN; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:38Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Tsao F.-Y.; Liu T.-Y.; Hsieh C.-F.; Bair M.-J.; Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Chien-Chuan Chen; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C. |
| 臺大學術典藏 |
2020-11-27T03:28:38Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; CHIEH-CHANG CHEN; Lee Y.-C.; Chen M.-J.; Chien-Chuan Chen; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2020-11-27T03:28:37Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEH-CHANG CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chien-Chuan Chen; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:36Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:36Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; Wu M.-S.; Chien-Chuan Chen; CHIEH-CHANG CHEN; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-27T03:28:35Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; CHIEH-CHANG CHEN; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chun-Chao Chang; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Wu M.-S.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
